Amgen Inc (AMGN)
268.94
+6.20
(+2.36%)
USD |
NASDAQ |
Apr 19, 16:00
269.10
+0.16
(+0.06%)
After-Hours: 17:43
Amgen Cash from Operations (Quarterly): 538.00M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 538.00M |
| September 30, 2023 | 2.76B |
| June 30, 2023 | 4.109B |
| March 31, 2023 | 1.064B |
| December 31, 2022 | 2.649B |
| September 30, 2022 | 2.978B |
| June 30, 2022 | 1.93B |
| March 31, 2022 | 2.164B |
| December 31, 2021 | 2.808B |
| September 30, 2021 | 2.418B |
| June 30, 2021 | 1.931B |
| March 31, 2021 | 2.104B |
| December 31, 2020 | 2.153B |
| September 30, 2020 | 3.368B |
| June 30, 2020 | 2.842B |
| March 31, 2020 | 2.134B |
| December 31, 2019 | 2.514B |
| September 30, 2019 | 3.377B |
| June 30, 2019 | 1.414B |
| March 31, 2019 | 1.845B |
| December 31, 2018 | 3.194B |
| September 30, 2018 | 3.273B |
| June 30, 2018 | 2.102B |
| March 31, 2018 | 2.727B |
| December 31, 2017 | 3.012B |
| Date | Value |
|---|---|
| September 30, 2017 | 3.454B |
| June 30, 2017 | 2.326B |
| March 31, 2017 | 2.385B |
| December 31, 2016 | 3.10B |
| September 30, 2016 | 2.662B |
| June 30, 2016 | 2.677B |
| March 31, 2016 | 1.915B |
| December 31, 2015 | 2.073B |
| September 30, 2015 | 2.892B |
| June 30, 2015 | 3.284B |
| March 31, 2015 | 1.482B |
| December 31, 2014 | 2.842B |
| September 30, 2014 | 2.741B |
| June 30, 2014 | 2.227B |
| March 31, 2014 | 1.142B |
| December 31, 2013 | 1.835B |
| September 30, 2013 | 1.807B |
| June 30, 2013 | 1.60B |
| March 31, 2013 | 1.049B |
| December 31, 2012 | 812.00M |
| September 30, 2012 | 1.723B |
| June 30, 2012 | 2.375B |
| March 31, 2012 | 972.00M |
| December 31, 2011 | 1.584B |
| September 30, 2011 | 969.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
538.00M
Minimum
Dec 2023
4.109B
Maximum
Jun 2023
2.382B
Average
2.418B
Median
Sep 2021
Cash from Operations (Quarterly) Benchmarks
| Gilead Sciences Inc | 2.169B |
| Johnson & Johnson | 7.863B |
| Eli Lilly and Co | -311.90M |
| Merck & Co Inc | 246.00M |
| Vertex Pharmaceuticals Inc | 234.60M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -27.09B |
| Cash from Financing (Quarterly) | 2.754B |
| Free Cash Flow | 7.359B |
| Free Cash Flow Per Share (Quarterly) | 0.5372 |
| Free Cash Flow to Equity (Quarterly) | -3.856B |
| Free Cash Flow to Firm (Quarterly) | 1.028B |
| Free Cash Flow Yield | 5.09% |